Litcius/Paper detail

Efficacy and safety exposure–response relationships of apalutamide in patients with metastatic castration-sensitive prostate cancer: results from the phase 3 TITAN study

Huybrecht T’jollyn, Oliver Ackaert, Caly Chien, Angela Lopez‐Gitlitz, Sharon McCarthy, Carlos Pérez Ruixo, Lawrence I. Karsh, Kim Chi, Simon Chowdhury, Juan-Jose Perez Ruixo, Neeraj Agarwal

2022Cancer Chemotherapy and Pharmacology13 citationsDOI

Topics & Concepts

PlaceboProstate cancerMedicineInternal medicineRashPharmacokineticsAdverse effectAntiandrogenOncologyPopulationPharmacologyCancerPathologyEnvironmental healthAlternative medicineProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentBone health and treatments
Efficacy and safety exposure–response relationships of apalutamide in patients with metastatic castration-sensitive prostate cancer: results from the phase 3 TITAN study | Litcius